Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cetuximab”

952 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 952 results

Early research (Phase 1)Study completedNCT01046266
What this trial is testing

Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Hoffmann-La Roche 62
Large-scale testing (Phase 3)Study completedNCT00362986
What this trial is testing

Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer

Who this might be right for
Dermatologic ComplicationsUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 116
Testing effectiveness (Phase 2)Study completedNCT01292356
What this trial is testing

Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response

Who this might be right for
Metastatic Colon Cancer
Poitiers University Hospital 28
Testing effectiveness (Phase 2)Study completedNCT00957853
What this trial is testing

Preoperative Treatment With Cetuximab and/or IMC-A12

Who this might be right for
Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center 16
Large-scale testing (Phase 3)Study completedNCT01969877
What this trial is testing

Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.

Who this might be right for
Locally Advanced Head and Neck Cancer
Lund University Hospital 298
Testing effectiveness (Phase 2)Study completedNCT00275951
What this trial is testing

Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
National Taiwan University Hospital 39
Not applicableUnknownNCT05873972
What this trial is testing

Multimodal Model for Efficacy Prediction Cetuximab in Colorectal Cancer Liver Metastasis Patient

Who this might be right for
Colorectal Cancer Liver Metastases
Fudan University 100
Testing effectiveness (Phase 2)Ended earlyNCT00109850
What this trial is testing

S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
SWOG Cancer Research Network 22
Testing effectiveness (Phase 2)Study completedNCT01326000
What this trial is testing

RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 169
Large-scale testing (Phase 3)Looking for participantsNCT07702032
What this trial is testing

Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)

Who this might be right for
Left-sided Colorectal Cancer
Genmab 960
Testing effectiveness (Phase 2)Study completedNCT00004865
What this trial is testing

Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy

Who this might be right for
Head and Neck Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00207077
What this trial is testing

Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors

Who this might be right for
Neoplasms
Eli Lilly and Company 33
Testing effectiveness (Phase 2)Study completedNCT00055419
What this trial is testing

Cetuximab in Patients Who Have Stage IV Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Eli Lilly and Company 744
Testing effectiveness (Phase 2)Study completedNCT01123811
What this trial is testing

Efficacy of Cetuximab in Combination With Irinotecan and 5- FU/FA in Treatment of Metastatic Gastric Cancer

Who this might be right for
Adenocarcinoma of Stomach or Esophagogastric Junction
Johannes Gutenberg University Mainz 45
Testing effectiveness (Phase 2)Study completedNCT00408564
What this trial is testing

Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
Medical University of South Carolina 39
Not applicableStudy completedNCT02241187
What this trial is testing

Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)WithdrawnNCT00725400
What this trial is testing

Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma

Who this might be right for
Colorectal Carcinoma
American Scitech International 450
Early research (Phase 1)UnknownNCT05019534
What this trial is testing

Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer

Who this might be right for
BRAF V600E-mutated /MSS Metastatic Colorectal CancerVemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal Antibody
West China Hospital 12
Testing effectiveness (Phase 2)Study completedNCT05510895
What this trial is testing

Neoadjuvant Encorafenib, Binimetinib and Cetuximab for Patients With BRAF V600E Mutated/pMMR Localized Colorectal Cancer

Who this might be right for
Colorectal CancerColon CancerBRAF V600E+2 more
AIO-Studien-gGmbH 2
Testing effectiveness (Phase 2)UnknownNCT00689702
What this trial is testing

Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
Institute of Oncology Ljubljana 43
Next Page